2003

Cooperated with the University of Hong Kong to successfully detect SARS virus specimens in 15 minutes, reported by major media

2006

Chaozhou reagent production workshop obtained the national GMP certification

2007

Honorary Certificate of Credit Enterprise

Obtained ISO9001, ISO13485 certification

2008

Won the "Model Award in Support of Women's Charity" jointly issued by the National Women's Federation and the China Women's Development Foundation  

2008 "Key Enterprise for Tax Creation"

Guangdong Hybribio Biotech Co., Ltd. and Chaozhou Hybribio Biochemistry Ltd. identified as high-tech enterprises

2009

Received the "Social Responsibility Award" from the Chinese Physician Association

2009 " Key Enterprise for Tax Creation"

2010

Won the "China Women's Charity Award" from the National Women's Federation and the China Women's Development Foundation  

2010 “ Key Enterprise for Tax Creation”  (chemical company)  

Advanced Company of Production Safety in Chaozhou in 2010

2011

2011 "Key Enterprise for Tax Creation"

Chaozhou Advanced Collective

Major taxpayers of the year 

Hybribio series products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.

2012

Awarded Top 10 Enterprises with Most Investment Value in China's Healthcare Industry in the 6th China Healthcare Industry Investment and Financing Summit

Became a supplier for mobilizing military supplies  

Biochip R & D and industrialization projects are listed as key projects in the “Twelfth Five-Year Plan” for the development of Guangdong's biomedical industry  

Established Guangdong HPV-Related Diseases Molecular Diagnostic Engineering Technology R & D Center

Guangdong Innovative enterprises

2013

Became the key enterprise of Guangdong's strategic emerging industries  

The Guangdong Provincial Economic and Information Commission and the Guangdong Provincial Department of Science and Technology announced “the 15th Guangdong Clean Production Enterprises List”  

Approved by the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee to establish a postdoctoral research station  

Hybribio serial products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.

2014

Guangdong Provincial Enterprise Technology Center  

"Biochip R & D and Industrialization" became a pilot project for the regional development of strategic emerging industries by the National Development and Reform Commission and won central and local financial support  

Hybribio serial products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.  

Hybribio's Chief Scientist Dr. Xie Longxu was selected in o the "Sailing Plan" to be trained as high-level talents

2015

Selected as an Enterprise with Intellectual Property Advantages in Chaozhou  

CT/NG/UU Real-time PCR Kit won the Third Prize of Chaozhou Science and Technology Progress Award  

Hearing Loss Susceptibility GenoArray Diagnostic Kit won the second prize of Chaozhou Science and Technology Progress Award  

Class A Medical Device Manufacturer for Quality Credit in Guangdong in 2015

2016

HPV Genotyping Diagnostic Kits and Gene Chip Preparation (ZL200710030723.6) method won the Gold Award of 2016 Chinese Invention Patent Award 

Thalassemia GenoArray Diagnostic Kit won the First Prize of Chaozhou Science and Technology Progress Award  

Class A Medical Device Manufacturer for Quality Credit in Guangdong in 2016

2017

Thalassemia GenoArray Diagnostic Kit won the First Prize of Chaozhou Science and Technology Progress Award    

2017 National Enterprise with Intellectual Property Advantages

National Application and Demonstration Center for Genetic Diagnostic Technology  

2018

The China Cancer Foundation awarded the "Social Welfare Award"     

Won the Technology Achievement Award of 2018 Hong Kong Awards for Industry and Commerce

Top 50 Biotechnological Innovative Enterprises in Guangdong, Hong Kong and Macau Greater Bay Area in 2018

Approved by Guangdong Provincial Department of Human Resources and Social Security to establish a doctoral workstation in Guangdong Province

2019

China Cancer Foundation awarded the Social Welfare Award   

Top 50 Leading Biotechnological Innovative Enterprises in Guangdong, Hong Kong and Macau Greater Bay Area in 2018

Top 100 Enterprises with Most Investment Value - Golden Bull Award for Listed Companies

Honor Award for the Cooperation and Development of Maternal and Child Health Industry   

Annual Rising Award for Listed Companies in Guangdong, Hong Kong, Macao Greater Bay Area in 2019